(Q34016819)

30 July 2017

title

Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS. (English)

1 reference

30 July 2017

Bacillus coagulans

1 reference

Larysa Hun

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

30 July 2017

published in

Postgraduate Medicine

1 reference

30 July 2017

volume

121

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

119-124

1 reference

AGA technical review on irritable bowel syndrome

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

Irritable bowel syndrome: a technical review for practice guideline development

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

Intestinal microecology and quality of life in irritable bowel syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

The use of probiotics in functional bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

Acid and bile tolerance of spore-forming lactic acid bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

Meta-analysis of probiotics for the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

The placebo effect in irritable bowel syndrome trials: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

Towards understanding molecular modes of probiotic action

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

Bacillus probiotics: spore germination in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

Coagulin, a bacteriocin-like inhibitory substance produced by Bacillus coagulans I4

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1984

21 January 2018

Identifiers

DOI

10.3810/PGM.2009.03.1984

1 reference

30 July 2017

1 reference